Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the ...

Six months into Donald Trump’s second term, his administration is at war with the federal judiciary, evading court orders ...

The complicated legal wrangling has been brought to a close after CureVac and BioNTech settled their mRNA patent litigation ...

The chapter on Pfizer and BioNTech’s mRNA patent feud with Germany’s CureVac is coming to a close, even as lawsuits over the ...

Pediatrician Deborah Greenhouse writes that South Carolina is at risk because of the U.S. government’s decision to defund almost $500 million in mRNA vaccine research funding.

HHS Secretary Robert F. Kennedy Jr. says the federal government is calling off around $500 million worth of vaccine ...

The settlement ends US mRNA patent disputes involving COVID-19 and influenza vaccines, while positioning GSK for additional ...

Messenger RNA vaccines, or mRNA, differ from traditional ones. Instead of growing a virus and weakening it to allow the body to engage its natural defenses, mRNA vaccines use pieces of genetic code to ...

Scientists have discovered the ability to “personalize” cancer treatments using cutting-edge genetic technology - but experts ...

US Health and Human Services is “winding down” its mRNA vaccine development and will instead fund other vaccine platforms ...

WASHINGTON -- So-called mRNA vaccines saved millions of lives during the COVID-19 pandemic — and now scientists are using ...